HK Stock Market Move | EDGE MEDICAL-B(02675) rose more than 12% in the afternoon, with the company's domestic sales ranking first among manufacturers and overseas orders experiencing explosive growth.

EDGE MEDICAL-B (02675) rose more than 12% in the afternoon, rising 11.33% as of the press release, reaching 64.85 Hong Kong dollars with a turnover of 351.746 million Hong Kong dollars. In terms of news, the National Medical Insurance Bureau recently introduced a fee guide for Siasun Robot&Automation surgery. Guosen stated that benefiting from the technological innovation, clinical demand, and policy dividends of the Siasun Robot&Automation surgery industry, the global and Chinese markets continue to grow rapidly, with the single-hole and natural cavity Siasun Robot&Automation segments in China showing particularly strong growth. It is recommended to actively monitor the import substitution and overseas progress of domestic Siasun Robot&Automation surgery manufacturers. Cathay Haitong released a research report stating that since the commercialization of the Jinfeng multi-pore cavity mirror surgery Siasun Robot&Automation in December 2022, they have sold 20 units of the Jinfeng multi-pore cavity mirror surgery Siasun Robot&Automation in China by 2024, ranking first among domestic Siasun Robot&Automation surgery manufacturers. In addition, since 2025, the internationalization engine of Jinfeng Medical has been fully launched, with overseas orders experiencing explosive growth. By the end of 2025, the company had signed global sales agreements for 118 core products, with 72 units going to foreign countries.